The Alliance for Regenerative Medicine Releases Q1 2019 Data Report, Highlighting Sector Trends and Metrics
09 mai 2019 10h46 HE
|
Alliance for Regenerative Medicine
WASHINGTON, D.C., May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at...
Predictive Technology Group Finalizes Board Committee Chair Appointments
09 mai 2019 09h00 HE
|
Predictive Technology Group, Inc.
SALT LAKE CITY , May 09, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical...
BioBridge Global adds two industry leaders to Regenerative Medicine Advisory Board
06 mai 2019 09h00 HE
|
BioBridge Global
San Antonio, Texas, May 06, 2019 (GLOBE NEWSWIRE) -- BioBridge Global has added two new members to its Regenerative Medicine Advisory Board, a group composed of industry leaders with a wide range of...
Predictive Technology Group Submits Application to List on NASDAQ
02 mai 2019 09h00 HE
|
Predictive Technology Group, Inc.
SALT LAKE CITY, May 02, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical...
Predictive Technology Group Names Christine Seward Senior Vice President of Sales and Marketing of Predictive Laboratories
25 avr. 2019 09h00 HE
|
Predictive Technology Group, Inc.
SALT LAKE CITY, April 25, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical...
Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean
17 avr. 2019 08h05 HE
|
Organovo, Inc.
SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a...
Hemostemix Announces Convertible Debenture Financing
15 avr. 2019 08h30 HE
|
Hemostemix Inc.
NOT FOR DISTRIBTUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 15, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...
Hemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
09 avr. 2019 08h30 HE
|
Hemostemix Inc.
CALGARY, Alberta, April 09, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has reached an enrollment...
Hemostemix Announces Appointment of Experienced Chief Medical Officer & President
01 avr. 2019 08h30 HE
|
Hemostemix Inc.
CALGARY, Alberta, April 01, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that Dr. Alan J. Jacobs, M.S.EE, M.D,...
Visiongain states that "Translational regenerative medicine market set to grow to $76bn by 2023".
28 mars 2019 06h16 HE
|
Visiongain Ltd
London, UK, March 28, 2019 (GLOBE NEWSWIRE) -- The high potential earning for companies from products aimed at repairing organs and tissues has led to an increase in the attention given to...